Cargando…

Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report

OBJECTIVE: Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurda, Dylan, Guduguntla, Geetha, Maingard, Julian, Kok, Hong Kuan, Lalloo, Shivendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224241/
https://www.ncbi.nlm.nih.gov/pubmed/32026176
http://dx.doi.org/10.1186/s42155-019-0059-z
_version_ 1783533864587624448
author Kurda, Dylan
Guduguntla, Geetha
Maingard, Julian
Kok, Hong Kuan
Lalloo, Shivendra
author_facet Kurda, Dylan
Guduguntla, Geetha
Maingard, Julian
Kok, Hong Kuan
Lalloo, Shivendra
author_sort Kurda, Dylan
collection PubMed
description OBJECTIVE: Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent. CASE REPORT: A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient’s menstrual cycle was restored 8 weeks after the procedure. CONCLUSION: Uterine AVM can be treated safely and effectively with UAE using PHIL.
format Online
Article
Text
id pubmed-7224241
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-72242412020-05-15 Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report Kurda, Dylan Guduguntla, Geetha Maingard, Julian Kok, Hong Kuan Lalloo, Shivendra CVIR Endovasc Case Report OBJECTIVE: Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent. CASE REPORT: A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient’s menstrual cycle was restored 8 weeks after the procedure. CONCLUSION: Uterine AVM can be treated safely and effectively with UAE using PHIL. Springer International Publishing 2019-05-17 /pmc/articles/PMC7224241/ /pubmed/32026176 http://dx.doi.org/10.1186/s42155-019-0059-z Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Kurda, Dylan
Guduguntla, Geetha
Maingard, Julian
Kok, Hong Kuan
Lalloo, Shivendra
Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
title Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
title_full Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
title_fullStr Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
title_full_unstemmed Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
title_short Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
title_sort precipitating hydrophobic injectable liquid (phil) embolic for the treatment of a uterine arteriovenous malformation: a technical report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224241/
https://www.ncbi.nlm.nih.gov/pubmed/32026176
http://dx.doi.org/10.1186/s42155-019-0059-z
work_keys_str_mv AT kurdadylan precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport
AT guduguntlageetha precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport
AT maingardjulian precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport
AT kokhongkuan precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport
AT lallooshivendra precipitatinghydrophobicinjectableliquidphilembolicforthetreatmentofauterinearteriovenousmalformationatechnicalreport